These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35508762)

  • 41. Metabolism, excretion, and pharmacokinetics of [
    Yamamura N; Mendel-Harary J; Brown K; Uchiyama M; Urasaki Y; Takahashi M; Warren V; Vashi V
    Xenobiotica; 2021 May; 51(5):549-563. PubMed ID: 33487061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration.
    Hoffmann M; Kumar G; Schafer P; Cedzik D; Capone L; Fong KL; Gu Z; Heller D; Feng H; Surapaneni S; Laskin O; Wu A
    Xenobiotica; 2011 Dec; 41(12):1063-75. PubMed ID: 21859393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism, excretion and pharmacokinetics of [
    Lam JL; Vaz A; Hee B; Liang Y; Yang X; Shaik MN
    Xenobiotica; 2017 Dec; 47(12):1064-1076. PubMed ID: 27866461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absorption, distribution, metabolism, and excretion of [¹⁴C]GDC-0449 (vismodegib), an orally active hedgehog pathway inhibitor, in rats and dogs: a unique metabolic pathway via pyridine ring opening.
    Yue Q; Chen YH; Mulder T; Deese A; Takahashi R; Rudewicz PJ; Reynolds M; Solon E; Hop CE; Wong H; Khojasteh SC
    Drug Metab Dispos; 2011 Jun; 39(6):952-65. PubMed ID: 21363998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease.
    Rocha JF; Ferreira JJ; Falcão A; Santos A; Pinto R; Nunes T; Almeida L; Soares-da-Silva P
    Clin Pharmacol Drug Dev; 2016 May; 5(3):232-40. PubMed ID: 27163503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects.
    Chen N; Wen L; Lau H; Surapaneni S; Kumar G
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):789-97. PubMed ID: 22037879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite.
    Glaenzel U; Jin Y; Hansen R; Schroer K; Rahmanzadeh G; Pfaar U; Jaap van Lier J; Borell H; Meissner A; Camenisch G; Zhao S
    Drug Metab Dispos; 2020 Oct; 48(10):873-885. PubMed ID: 32665418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics, mass balance, metabolism, and excretion of the liver-targeted acetyl-CoA carboxylase inhibitor PF-05221304 (clesacostat) in humans.
    Ryder TF; Bergman A; King-Ahmad A; Amin NB; Lall MS; Ballard TE; Kalgutkar AS
    Xenobiotica; 2022 Mar; 52(3):240-253. PubMed ID: 35382680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the Absorption, Metabolism, and Excretion of a Single Oral 1-mg Dose of Tropifexor in Healthy Male Subjects and the Concentration Dependence of Tropifexor Metabolism.
    Wang-Lakshman L; Miao Z; Wang L; Gu H; Kagan M; Gu J; McNamara E; Walles M; Woessner R; Camenisch G; Einolf HJ; Chen J
    Drug Metab Dispos; 2021 Jul; 49(7):548-562. PubMed ID: 33952610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.
    Liu H; Michmerhuizen MJ; Lao Y; Wan K; Salem AH; Sawicki J; Serby M; Vaidyanathan S; Wong SL; Agarwal S; Dunbar M; Sydor J; de Morais SM; Lee AJ
    Drug Metab Dispos; 2017 Mar; 45(3):294-305. PubMed ID: 27993930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mass balance study of [
    Ge X; Ma S; Yan S; Wu Y; Chen C; Tang C; Zhan Y; Bian YC; Shen K; Feng S; Gao X; Zhong D; Zhang H; Miao LY; Diao XX
    Xenobiotica; 2023 Feb; 53(2):69-83. PubMed ID: 36745485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics, mass balance, tissue distribution, metabolism, and excretion of [
    Grillo MP; Sukhun R; Bashir M; Ashcraft L; Morgan BP
    Xenobiotica; 2024 Sep; 54(9):670-685. PubMed ID: 39058619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro effects of opicapone on activity of human UDP-glucuronosyltransferases isoforms.
    Wang Z; Wang Z; Wang X; Lv X; Yin H; Fan X; Yan M; Jia Y; Jiang L; Xia Y; Li W; Liu Y
    Toxicol Lett; 2022 Aug; 367():3-8. PubMed ID: 35810997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and Safety of Opicapone for Motor Fluctuations as an Adjuvant to Levodopa Therapy in Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Kwak N; Park J; Kang HY; Lee MJ; Suh JK; Lee H
    J Parkinsons Dis; 2022; 12(3):773-783. PubMed ID: 35180134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
    Muirhead GJ; Rance DJ; Walker DK; Wastall P
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and Humans.
    Kong R; Ma J; Hwang S; Goodwin E; Northcutt V; Babiak J; Almstead N; McIntosh J
    Drug Metab Dispos; 2020 Apr; 48(4):317-325. PubMed ID: 31980502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.